Literature DB >> 34101133

Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.

Q Li1, D Tian2, J Cen3, L Duan4, W Xia5.   

Abstract

AIMS: To investigate genotype and phenotype of congenital nephrogenic diabetes insipidus caused by AVPR2 mutations, which is rare and limitedly studied in Chinese population.
METHODS: 88 subjects from 28 families with NDI in a department (Beijing, PUMCH) were screened for AVPR2 mutations. Medical records were retrospectively reviewed and characterized. Genotype and phenotype analysis was performed.
RESULTS: 23 AVPR2 mutations were identified, including six novel mutations (p.Y117D, p.W208R, p.L313R, p.S127del, p.V162Sfs*30 and p.G251Pfs*96). The onset-age ranged from 1 week to 3 years. Common presentations were polydipsia and polyuria (100%) and intermittent fever (57%). 21% and 14% of patients had short stature and mental impairment. Urine SG and osmolality were decreased, while serum osmolality and sodium were high. Urological ultrasonography results showed hydronephrosis of the kidney (52%), dilation of the ureter (48%), and thickened bladder wall or increased residual urine (32%), led to intermittent urethral catheterization (7%), cystostomy (11%) and binary nephrostomy (4%). Urological defects were developed in older patients. Genotype and phenotype analysis revealed patients with non-missense mutations had higher levels of serum sodium than missense mutations.
CONCLUSION: In the first and largest case series of NDI caused by AVPR2 mutations in Chinese population, we established genetic profile and characterized clinical data, reporting six novel mutations. Further, we found genotype was associated with phenotype. This knowledge broadens genotype and phenotype spectrum of rare congenital NDI caused by AVPR2 mutations, and provides basis for studying molecular biology of AVPR2.
© 2021. Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  Aquaporin 2; Mutation; Nephrogenic diabetes insipidus; Vasopressin V2 receptor; Water resorption

Mesh:

Substances:

Year:  2021        PMID: 34101133     DOI: 10.1007/s40618-021-01607-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  Hypocaloric dwarfism and hydronephrosis in diabetes insipidus.

Authors:  M VEST; J D CRAWFORD
Journal:  Am J Dis Child       Date:  1963-02

2.  Renal (vasopressin-resistant) diabetes insipidus; definition of the effects of a homeostatic limitation in capacity to conserve water on the physical, intellectual and emotional development of a child.

Authors:  D A HILLMAN; O NEYZI; P PORTER; A CUSHMAN; N B TALBOT
Journal:  Pediatrics       Date:  1958-03       Impact factor: 7.124

3.  Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.

Authors:  Jing Cen; Min Nie; Lian Duan; Feng Gu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.

Authors:  K Pasel; A Schulz; K Timmermann; K Linnemann; M Hoeltzenbein; J Jääskeläinen; A Grüters; G Filler; T Schöneberg
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

5.  [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years].

Authors:  Hui Li; Cheng-Ye Ji; Xin-Nan Zong; Ya-Qin Zhang
Journal:  Zhonghua Er Ke Za Zhi       Date:  2009-07

6.  X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.

Authors:  D G Bichet; G N Hendy; M Lonergan; M F Arthus; S Ligier; Z Pausova; R Kluge; H Zingg; P Saenger; E Oppenheimer
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

7.  Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus.

Authors:  R S Wildin; M J Antush; R L Bennett; J M Schoof; C R Scott
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.